{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "decreases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uniprot:Q8TEK3",
      "entity_text" : "Dot1L",
      "entity_type" : "protein"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "uaz:UAZ04995",
      "entity_text" : "SGC0946",
      "entity_type" : "protein"
    },
    "hypothesis_information" : false
  },
  "verbose_text" : "In this study, we added SGC0946 (inhibitor of Dot1L, a histone H3K79 methyltransferase) along with our previous cocktail of ascorbic acid (vitamin C) and 2i (inhibitors to mitogen activated protein [MAP] kinase and glycogen synthetase kinase), in conjunction with OSKM to reprogram MEFs to iPSCs at an efficiency of ~ 40% within 6 days.",
  "reading_complete" : "2020-08-08T11:09:50Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-08T11:05:27Z",
  "trigger" : "inhibitor",
  "evidence" : [ "SGC0946 (inhibitor of Dot1L" ],
  "pmc_id" : "6555151",
  "score" : 0
}